Evacetrapib (LY2484595)-分析测试百科网

Evacetrapib (LY2484595)

面议

品牌：阿拉丁
厂商性质：生产商
产地类别：国产
产地：上海
货期：现货
服务地域：全国
规格：3
近期咨询：1

分子式 C31H36F6N6O2 分子量638.65 属性溶解性 DMSO 12.8 mg/mL Water <1 mg/mL Ethanol 12.8 mg/mL 存贮条件储存温度-20°C //decorateTable('p

上海阿拉丁生化科技股份有限公司

上海阿拉丁生化科技股份有限公司

加入购物车

加入购物车获取底价在线咨询

400-6699-117 转1000

货号	CAS号	操作
E128064-100mg	1186486-62-3	询底价
E128064-25mg	1186486-62-3	询底价
E128064-5mg	1186486-62-3	询底价

耗材描述

分子式 C₃₁H₃₆F₆N₆O₂
分子量638.65

属性

溶解性	DMSO 12.8 mg/mL Water <1 mg/mL Ethanol 12.8 mg/mL
存贮条件	储存温度-20°C

描述

产品介绍	Evacetrapib (LY2484595)是高活性CETP选择性抑制剂，IC50为5.5 nM，能在不增加醛固酮和血压的情况下提高高密度脂蛋白胆固醇。
生化机理	Evacetrapib (LY2484595) inhibits human plasma CETP protein with IC50 of 26 nM. Evacetrapib (LY2484595) (< 10 μM) does not induce aldosterone or cortisol synthesis in H295R cells. Evacetrapib (LY2484595) (30 mg/kg, orally) results in 98.4%, 98.6%, and 18.4% inhibition of CETP activity at 4 hours, 8 hours and 24 hours post dose respectively in human ApoAI and CETP double transgenic mice. Evacetrapib (LY2484595) (30 mg/kg) results in 129.7% increase in HDL-C 8 hours after oral administration. The ED50 values of CETP inhibitory activity 8 hours post oral dosing for Evacetrapib (LY2484595) in two dose-response studies are calculated to be 3.5 mg/kg and 4.1 mg/kg respectively. Evacetrapib (LY2484595) (< 200 mg/kg) does not increase blood pressure in Zucker diabetic fatty rats.
别名	LY2484595;LY 2484595;LY-2484595;反式-4-(((5S)-5-(((3,5-双(三氟甲基)苯基)甲基)(2-甲基-2H-四氮唑-5-基)氨基)-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基)甲基)环己烷羧酸;;LY2484595;LY 2484595;LY-2484595;trans-4-(((5s)-5-(((3,5-bis(trifluoromethyl)phenyl)methyl)(2-methyl-2h-tetrazol-5-yl)amino)-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl)methyl)cyclohexanecarboxylic acid

猜你喜欢

感兴趣产品